IgG Mediated, Delayed

Type Type II
Time frame (exogenous exposure) 2-7 days (drug)
Immune Reactant Ab (IgG) mediated
Antigen Cell-/ Matrix- bound
Effector forDamage  Pathway Complement, phagocyte, FcR+ cells, NK cells, recptors themselves Local activation of complement pathway – Opsonization/MAC (cytotoxicity); obstruction/activation of receptor (dysfunction)
Note vs type III: